Genesis Therapeutics
Home - Genesis Molecular AI
Burlingame, United States · Founded 2019 · $256.1M raised
- Headquarters
- Burlingame
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- genesistherapeutics.ai
- Total Funding
- $256.1M
- Last Round
- $200.0M Series BAug 2023
- Rounds
- 3
About
Genesis Therapeutics uses its proprietary GEMS platform, combining deep learning and molecular simulations, to discover small molecule drugs for challenging disease targets. Backed by over $300M from Andreessen Horowitz, NVIDIA, and Fidelity, the company has established major platform collaborations with Gilead, Genentech, and Incyte.
Summary
Genesis Therapeutics is an Artificial Intelligence company based in Burlingame, United States, founded in 2019. It has raised $256.1M in total across 3 rounds, most recently a $200.0M Series B round in Aug 2023.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...